Vasomotor Symptoms of Menopause Treatment Market Report

Global and China Vasomotor Symptoms of Menopause Treatment Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 14, 2022
  • PAGES：179
  • REPORT CODE：GMM1375342
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Vasomotor Symptoms of Menopause Treatment industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • EndoCeutics, Inc

    • Mithra Pharmaceuticals SA

    • Pherin Pharmaceuticals, Inc

    • Euroscreen SA

    • Amgen Inc

    • Radius Health, Inc

    • TherapeuticsMD, Inc

    • Pivot Pharmaceuticals Inc

    • MenoGeniX, Inc

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Estetrol

    • Fezolinetant

    • FP-101

    • HBN-2

    • Others

    Application:

    • Hospital

    • Homecare

    • Clinic

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Vasomotor Symptoms of Menopause Treatment Industry Overview

      • 1.1.1 Vasomotor Symptoms of Menopause Treatment Market Scope and Market Segments

      • 1.1.2 Vasomotor Symptoms of Menopause Treatment Industry Characteristics

      • 1.1.3 Global and China Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Vasomotor Symptoms of Menopause Treatment Production Value and Growth Rate (2017-2028)

    • 1.2 Global Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Estetrol

      • 1.2.2 Fezolinetant

      • 1.2.3 FP-101

      • 1.2.4 HBN-2

      • 1.2.5 Others

    • 1.3 Global Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital

      • 1.3.2 Homecare

      • 1.3.3 Clinic

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Vasomotor Symptoms of Menopause Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Vasomotor Symptoms of Menopause Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Vasomotor Symptoms of Menopause Treatment Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Vasomotor Symptoms of Menopause Treatment Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Vasomotor Symptoms of Menopause Treatment Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Vasomotor Symptoms of Menopause Treatment Industry Porter's Five Forces Model Analysis

      • 2.2.3 Vasomotor Symptoms of Menopause Treatment Industry PEST Analysis

    • 2.3 Vasomotor Symptoms of Menopause Treatment Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Vasomotor Symptoms of Menopause Treatment Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Vasomotor Symptoms of Menopause Treatment Industry

    Chapter 3 Global and China Vasomotor Symptoms of Menopause Treatment Market, by Manufacturer

    • 3.1 Global and China Vasomotor Symptoms of Menopause Treatment Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Vasomotor Symptoms of Menopause Treatment Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Vasomotor Symptoms of Menopause Treatment Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Vasomotor Symptoms of Menopause Treatment Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Vasomotor Symptoms of Menopause Treatment Market Top 3 Players

    Chapter 4 Global and China Vasomotor Symptoms of Menopause Treatment Market, by Type (2017-2028)

    • 4.1 Vasomotor Symptoms of Menopause Treatment Market Trend, by Type

    • 4.2 Global Vasomotor Symptoms of Menopause Treatment Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Vasomotor Symptoms of Menopause Treatment Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Vasomotor Symptoms of Menopause Treatment Price Trend, by Type (2017-2028)

    • 4.3 China Vasomotor Symptoms of Menopause Treatment Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Vasomotor Symptoms of Menopause Treatment Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Vasomotor Symptoms of Menopause Treatment Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Vasomotor Symptoms of Menopause Treatment Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Vasomotor Symptoms of Menopause Treatment Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Vasomotor Symptoms of Menopause Treatment Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Vasomotor Symptoms of Menopause Treatment Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Vasomotor Symptoms of Menopause Treatment Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Vasomotor Symptoms of Menopause Treatment Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Vasomotor Symptoms of Menopause Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Vasomotor Symptoms of Menopause Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Vasomotor Symptoms of Menopause Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Vasomotor Symptoms of Menopause Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Vasomotor Symptoms of Menopause Treatment Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Vasomotor Symptoms of Menopause Treatment Market Analysis

    • 7.1 North America Vasomotor Symptoms of Menopause Treatment Market, by Type

    • 7.2 North America Vasomotor Symptoms of Menopause Treatment Market, by Application

    • 7.3 North America Vasomotor Symptoms of Menopause Treatment Market Analysis and Forecast, by Country

      • 7.3.1 United States Vasomotor Symptoms of Menopause Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Vasomotor Symptoms of Menopause Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Vasomotor Symptoms of Menopause Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Vasomotor Symptoms of Menopause Treatment Market Analysis

    • 8.1 Europe Vasomotor Symptoms of Menopause Treatment Market, by Type

    • 8.2 Europe Vasomotor Symptoms of Menopause Treatment Market, by Application

    • 8.3 Europe Vasomotor Symptoms of Menopause Treatment Market Analysis and Forecast, by Country

      • 8.3.1 Germany Vasomotor Symptoms of Menopause Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Vasomotor Symptoms of Menopause Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Vasomotor Symptoms of Menopause Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Vasomotor Symptoms of Menopause Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Vasomotor Symptoms of Menopause Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Vasomotor Symptoms of Menopause Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Vasomotor Symptoms of Menopause Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Vasomotor Symptoms of Menopause Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Vasomotor Symptoms of Menopause Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Vasomotor Symptoms of Menopause Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Vasomotor Symptoms of Menopause Treatment Market Analysis

    • 9.1 APAC Vasomotor Symptoms of Menopause Treatment Market, by Type

    • 9.2 APAC Vasomotor Symptoms of Menopause Treatment Market, by Application

    • 9.3 APAC Vasomotor Symptoms of Menopause Treatment Market Analysis and Forecast, by Country

      • 9.3.1 China Vasomotor Symptoms of Menopause Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Vasomotor Symptoms of Menopause Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Vasomotor Symptoms of Menopause Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Vasomotor Symptoms of Menopause Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Vasomotor Symptoms of Menopause Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Vasomotor Symptoms of Menopause Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Vasomotor Symptoms of Menopause Treatment Market Analysis

    • 10.1 Latin America, Middle East and Africa Vasomotor Symptoms of Menopause Treatment Market, by Type

    • 10.2 Latin America, Middle East and Africa Vasomotor Symptoms of Menopause Treatment Market, by Application

    • 10.3 Latin America, Middle East and Africa Vasomotor Symptoms of Menopause Treatment Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Vasomotor Symptoms of Menopause Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Vasomotor Symptoms of Menopause Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Vasomotor Symptoms of Menopause Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Vasomotor Symptoms of Menopause Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Vasomotor Symptoms of Menopause Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Vasomotor Symptoms of Menopause Treatment Company Profiles

      • 11.1 EndoCeutics, Inc

        • 11.1.1 EndoCeutics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 EndoCeutics, Inc Vasomotor Symptoms of Menopause Treatment Product Profiles, Application and Specification

        • 11.1.3 EndoCeutics, Inc Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Mithra Pharmaceuticals SA

        • 11.2.1 Mithra Pharmaceuticals SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Mithra Pharmaceuticals SA Vasomotor Symptoms of Menopause Treatment Product Profiles, Application and Specification

        • 11.2.3 Mithra Pharmaceuticals SA Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Pherin Pharmaceuticals, Inc

        • 11.3.1 Pherin Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Pherin Pharmaceuticals, Inc Vasomotor Symptoms of Menopause Treatment Product Profiles, Application and Specification

        • 11.3.3 Pherin Pharmaceuticals, Inc Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Euroscreen SA

        • 11.4.1 Euroscreen SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Euroscreen SA Vasomotor Symptoms of Menopause Treatment Product Profiles, Application and Specification

        • 11.4.3 Euroscreen SA Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Amgen Inc

        • 11.5.1 Amgen Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Amgen Inc Vasomotor Symptoms of Menopause Treatment Product Profiles, Application and Specification

        • 11.5.3 Amgen Inc Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Radius Health, Inc

        • 11.6.1 Radius Health, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Radius Health, Inc Vasomotor Symptoms of Menopause Treatment Product Profiles, Application and Specification

        • 11.6.3 Radius Health, Inc Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 TherapeuticsMD, Inc

        • 11.7.1 TherapeuticsMD, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 TherapeuticsMD, Inc Vasomotor Symptoms of Menopause Treatment Product Profiles, Application and Specification

        • 11.7.3 TherapeuticsMD, Inc Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Pivot Pharmaceuticals Inc

        • 11.8.1 Pivot Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Product Profiles, Application and Specification

        • 11.8.3 Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 MenoGeniX, Inc

        • 11.9.1 MenoGeniX, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 MenoGeniX, Inc Vasomotor Symptoms of Menopause Treatment Product Profiles, Application and Specification

        • 11.9.3 MenoGeniX, Inc Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Vasomotor Symptoms of Menopause Treatment Industry Investment Prospect and Risk Assessment

    • 12.1 Vasomotor Symptoms of Menopause Treatment Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Vasomotor Symptoms of Menopause Treatment Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure China Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Global Vasomotor Symptoms of Menopause Treatment Production Value and Growth Rate (2017-2028)

    • Figure China Vasomotor Symptoms of Menopause Treatment Production Value and Growth Rate (2017-2028)

    • Figure Global Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Estetrol (2017-2028)

    • Figure Global Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Fezolinetant (2017-2028)

    • Figure Global Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of FP-101 (2017-2028)

    • Figure Global Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of HBN-2 (2017-2028)

    • Figure Global Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Others (2017-2028)

    • Figure Global Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Homecare (2017-2028)

    • Figure Global Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Clinic (2017-2028)

    • Figure North America Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Vasomotor Symptoms of Menopause Treatment Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Vasomotor Symptoms of Menopause Treatment Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Vasomotor Symptoms of Menopause Treatment Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Vasomotor Symptoms of Menopause Treatment Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Vasomotor Symptoms of Menopause Treatment Market Share, by Manufacturer in 2021

    • Figure Global and China Vasomotor Symptoms of Menopause Treatment Market Share, by Manufacturer in 2022

    • Table Global Vasomotor Symptoms of Menopause Treatment Sales Volume, by Type (2017-2028)

    • Table Global Vasomotor Symptoms of Menopause Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume Share, by Type (2017-2028)

    • Table Global Vasomotor Symptoms of Menopause Treatment Sales Value, by Type (2017-2028)

    • Table Global Vasomotor Symptoms of Menopause Treatment Sales Value Share, by Type (2017-2028)

    • Figure Global Vasomotor Symptoms of Menopause Treatment Price Trend, by Type (2017-2028)

    • Table China Vasomotor Symptoms of Menopause Treatment Sales Volume, by Type (2017-2028)

    • Table China Vasomotor Symptoms of Menopause Treatment Sales Volume Share, by Type (2017-2028)

    • Figure China Vasomotor Symptoms of Menopause Treatment Sales Volume Share, by Type (2017-2028)

    • Table China Vasomotor Symptoms of Menopause Treatment Sales Value, by Type (2017-2028)

    • Table China Vasomotor Symptoms of Menopause Treatment Sales Value Share, by Type (2017-2028)

    • Figure China Vasomotor Symptoms of Menopause Treatment Price Trend, by Type (2017-2028)

    • Table Global Vasomotor Symptoms of Menopause Treatment Sales Volume, by Application (2017-2028)

    • Table Global Vasomotor Symptoms of Menopause Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Global Vasomotor Symptoms of Menopause Treatment Sales Volume Share, by Application (2017-2028)

    • Table Global Vasomotor Symptoms of Menopause Treatment Sales Value, by Application (2017-2028)

    • Table Global Vasomotor Symptoms of Menopause Treatment Sales Value Share, by Application (2017-2028)

    • Figure Global Vasomotor Symptoms of Menopause Treatment Sales Value Share, by Application (2017-2028)

    • Table China Vasomotor Symptoms of Menopause Treatment Sales Volume, by Application (2017-2028)

    • Table China Vasomotor Symptoms of Menopause Treatment Sales Volume Share, by Application (2017-2028)

    • Figure China Vasomotor Symptoms of Menopause Treatment Sales Volume Share, by Application (2017-2028)

    • Table China Vasomotor Symptoms of Menopause Treatment Sales Value, by Application (2017-2028)

    • Table China Vasomotor Symptoms of Menopause Treatment Sales Value Share, by Application (2017-2028)

    • Figure China Vasomotor Symptoms of Menopause Treatment Sales Value Share, by Application (2017-2028)

    • Figure China Vasomotor Symptoms of Menopause Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure North America Vasomotor Symptoms of Menopause Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Vasomotor Symptoms of Menopause Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Vasomotor Symptoms of Menopause Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Vasomotor Symptoms of Menopause Treatment Production, Import, Consumption and Export (2017-2022)

    • Table North America Vasomotor Symptoms of Menopause Treatment Sales Volume, by Type (2017-2028)

    • Table North America Vasomotor Symptoms of Menopause Treatment Sales Volume Share, by Type (2017-2028)

    • Figure North America Vasomotor Symptoms of Menopause Treatment Sales Volume Share, by Type (2017-2028)

    • Table North America Vasomotor Symptoms of Menopause Treatment Sales Volume, by Application (2017-2028)

    • Table North America Vasomotor Symptoms of Menopause Treatment Sales Volume Share, by Application (2017-2028)

    • Figure North America Vasomotor Symptoms of Menopause Treatment Sales Volume Share, by Application (2017-2028)

    • Figure United States Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure United States Vasomotor Symptoms of Menopause Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Canada Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Vasomotor Symptoms of Menopause Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Vasomotor Symptoms of Menopause Treatment Sales Value and Growth Rate (2017-2028)

    • Table Europe Vasomotor Symptoms of Menopause Treatment Sales Volume, by Type (2017-2028)

    • Table Europe Vasomotor Symptoms of Menopause Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Europe Vasomotor Symptoms of Menopause Treatment Sales Volume Share, by Type (2017-2028)

    • Table Europe Vasomotor Symptoms of Menopause Treatment Sales Volume, by Application (2017-2028)

    • Table Europe Vasomotor Symptoms of Menopause Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Europe Vasomotor Symptoms of Menopause Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Germany Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Vasomotor Symptoms of Menopause Treatment Sales Value and Growth Rate (2017-2028)

    • Figure UK Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure UK Vasomotor Symptoms of Menopause Treatment Sales Value and Growth Rate (2017-2028)

    • Figure France Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure France Vasomotor Symptoms of Menopause Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Italy Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Vasomotor Symptoms of Menopause Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Vasomotor Symptoms of Menopause Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Spain Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Vasomotor Symptoms of Menopause Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Vasomotor Symptoms of Menopause Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Poland Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Vasomotor Symptoms of Menopause Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Russia Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Vasomotor Symptoms of Menopause Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Vasomotor Symptoms of Menopause Treatment Sales Value and Growth Rate (2017-2028)

    • Table APAC Vasomotor Symptoms of Menopause Treatment Sales Volume, by Type (2017-2028)

    • Table APAC Vasomotor Symptoms of Menopause Treatment Sales Volume Share, by Type (2017-2028)

    • Figure APAC Vasomotor Symptoms of Menopause Treatment Sales Volume Share, by Type (2017-2028)

    • Table APAC Vasomotor Symptoms of Menopause Treatment Sales Volume, by Application (2017-2028)

    • Table APAC Vasomotor Symptoms of Menopause Treatment Sales Volume Share, by Application (2017-2028)

    • Figure APAC Vasomotor Symptoms of Menopause Treatment Sales Volume Share, by Application (2017-2028)

    • Figure China Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure China Vasomotor Symptoms of Menopause Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Japan Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Vasomotor Symptoms of Menopause Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Vasomotor Symptoms of Menopause Treatment Sales Value and Growth Rate (2017-2028)

    • Figure India Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure India Vasomotor Symptoms of Menopause Treatment Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Vasomotor Symptoms of Menopause Treatment Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Vasomotor Symptoms of Menopause Treatment Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Vasomotor Symptoms of Menopause Treatment Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Vasomotor Symptoms of Menopause Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Vasomotor Symptoms of Menopause Treatment Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Vasomotor Symptoms of Menopause Treatment Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Vasomotor Symptoms of Menopause Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Vasomotor Symptoms of Menopause Treatment Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Vasomotor Symptoms of Menopause Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Vasomotor Symptoms of Menopause Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Vasomotor Symptoms of Menopause Treatment Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Vasomotor Symptoms of Menopause Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Vasomotor Symptoms of Menopause Treatment Sales Value and Growth Rate (2017-2028)

    • Table EndoCeutics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table EndoCeutics, Inc Product Profiles, Application and Specification

    • Table EndoCeutics, Inc Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Mithra Pharmaceuticals SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Mithra Pharmaceuticals SA Product Profiles, Application and Specification

    • Table Mithra Pharmaceuticals SA Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pherin Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pherin Pharmaceuticals, Inc Product Profiles, Application and Specification

    • Table Pherin Pharmaceuticals, Inc Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Euroscreen SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Euroscreen SA Product Profiles, Application and Specification

    • Table Euroscreen SA Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Amgen Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Amgen Inc Product Profiles, Application and Specification

    • Table Amgen Inc Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Radius Health, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Radius Health, Inc Product Profiles, Application and Specification

    • Table Radius Health, Inc Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table TherapeuticsMD, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table TherapeuticsMD, Inc Product Profiles, Application and Specification

    • Table TherapeuticsMD, Inc Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pivot Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pivot Pharmaceuticals Inc Product Profiles, Application and Specification

    • Table Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table MenoGeniX, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table MenoGeniX, Inc Product Profiles, Application and Specification

    • Table MenoGeniX, Inc Vasomotor Symptoms of Menopause Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US